Diabetes Setback, PTV News: Mar 16, 2010




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Diabetes Setback, PTV News: Mar 16, 2010
Released on: March 16, 2010. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
  • Summary
  • Transcript
  • Participants
  • Company
FDA turns down MannKind's inhaled insulin drug
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
Mel Hemamda
Advisor
PharmaVentures

Mel is an experienced business advisor with expertise in evaluating and executing pharmaceutical business development opportunities. His current focus is in transaction management, where he is involved in managing simultaneous transaction projects on behalf of clients seeking to divest or acquire pharmaceutical assets. In this role, his responsibility includes value proposition development, driving the business development campaign and building deal structure scenarios. Mel is multilingual, holds a BSc. (Hons) in Business Management and an MBA from Oxford Brookes.
Food and Drug Administration (FDA)
The Food and Drug Administration (FDA or USFDA) is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments, responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
MannKind
MannKind Corporation, based in Valencia, California, is a biopharmaceutical company that focuses on the discovery, development and commercialisation of therapeutic products for diseases such as diabetes and cancer.
PharmaVentures Ltd
PharmaVentures is a company that has proven success in deals and alliances.

PharmaVentures offers:


• Over 18 years of healthcare industry experience

• Experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments

• Over 40 specialist advisors, analysts and researchers

• Skills honed in many countries - 80% of its business comes from outside the UK